Publications

Proton Beam Therapy for Early Breast Cancer: A Systematic Review and Meta-analysis of Clinical Outcomes.

Holt F. et al, (2023), Int J Radiat Oncol Biol Phys, 117, 869 - 882

Authors' reply to Oke and Welch.

Darby SC. et al, (2023), BMJ, 382

Ki67 and breast cancer mortality in women with invasive breast cancer.

Probert J. et al, (2023), JNCI Cancer Spectr, 7

Breast cancer mortality in 500 000 women with early invasive breast cancer diagnosed in England, 1993-2015: population based observational cohort study.

Taylor C. et al, (2023), BMJ, 381

Risk of breast cancer death after a diagnosis of early invasive breast cancer.

MacKenzie M. et al, (2023), BMJ, 381

Should patients requiring radiotherapy for breast cancer be treated with proton beam therapy?

Kirby AM. et al, (2023), BMJ, 381

Radiotherapy to regional nodes in early breast cancer: Individual-patient-data meta-analysis of 14,324 women in 16 trial

Taylor CAROLYN., (2023), The Lancet

Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials.

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Electronic address: bc.overview@ctsu.ox.ac.uk None. and Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) None., (2023), Lancet, 401, 1277 - 1292

Proton Beam Therapy in Breast Cancer Patients: The UK PARABLE Trial is Recruiting

Kirby AM. et al, (2023), Clinical Oncology

Exposure of the heart and cardiac valves in women irradiated for breast cancer 1970-2009.

Duane FK. et al, (2022), Clin Transl Radiat Oncol, 36, 132 - 139

Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality.

Kerr AJ. et al, (2022), Cancer Treat Rev, 105

Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2022), Lancet Oncol, 23, 382 - 392

Exposure of the oesophagus in breast cancer radiotherapy: A systematic review of oesophagus doses published 2010-2020.

Duane FK. et al, (2021), Radiother Oncol, 164, 261 - 267

Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials.

Early Breast Cancer Trialists’ Collaborative group (EBCTCG) None., (2021), Lancet Oncol, 22, 1139 - 1150

Exposure of the oesophagus in breast cancer radiotherapy: A systematic review of oesophageal doses published 2013–2018

Duane F. et al, (2020), European Journal of Cancer, 138, S83 - S84

Cardiac mortality after radiotherapy, chemotherapy and endocrine therapy for breast cancer: Cohort study of 2 million women from 57 cancer registries in 22 countries.

Henson KE. et al, (2020), Int J Cancer, 147, 1437 - 1449

Eligibility for Partial Breast Radiotherapy in England.

Taylor CW. et al, (2020), Clin Oncol (R Coll Radiol), 32, 217 - 220

Heart failure after treatment for breast cancer.

Boekel NB. et al, (2020), Eur J Heart Fail, 22, 366 - 374

Heart failure after treatment for breast cancer

Taylor C. and DARBY S., (2019), European Journal of Heart Failure

International Variation in Criteria for Internal Mammary Chain Radiotherapy.

Duane FK. et al, (2019), Clin Oncol (R Coll Radiol), 31, 453 - 461

Cookies on this website

Publications